Pharmacist-Administered Injectable Contraception Can Help Fill Gaps in Care

News
Video

A conversation with Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, clinical associate professor at University at Buffalo.

In the United States, over 65% of women between the ages of 15 and 49 currently use some form of contraception. Of those, 14% reported using the pill and 10.4% said they use long-acting reversible methods, such as intrauterine devices or contraceptive implants.1 Access to contraception is critical. However, depending on the state, between 17% and 53% of patients currently live in a contraception desert, where access to contraception is limited.2

As the most accessible members of the health care team, pharmacists are well positioned to help improve access to contraception. In a recent review published in the Journal of the American Pharmacists Association, investigators assessed the feasibility, applicability, and satisfaction of pharmacist-administered injectable contraception.3 The study found that it can be beneficial, accessible, and convenient for patients.

Drug Topics® recently sat down with Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, clinical associate professor at University at Buffalo and an author on the study, to discuss why community pharmacists are well-positioned to provide injectable contraception, as well as how pharmacists and patients view the service.

“Community pharmacists … [with] their current scope of practice and ability to administer vaccinations means that contraceptive injection techniques are training that they already have,” Cieri-Hutcherson said.

“Pharmacists have the opportunity to really address a large gap in contraceptive access,” she added. “Over 19 million females of reproductive age in the US reside in a contraceptive desert, which means that they are unable to easily access a health clinic that offers the full range of contraceptive methods.”

References
1. Contraceptive Use. Report. National Center for Health Statistics. December 15, 2023. Accessed March 17, 2025. https://www.cdc.gov/nchs/fastats/contraceptive.htm
2. Barber JS, Ela E, Gatny H, et al. Contraceptive Desert? Black-White Differences in Characteristics of Nearby Pharmacies. J Racial Ethn Health Disparities. 2019 Aug;6(4):719-732. doi: 10.1007/s40615-019-00570-3. Epub 2019 Feb 20. PMID: 30788813; PMCID: PMC6660992.
3. Cieri-Hutcherson NE, Hutcherson TC, Bradley EM, et al. Mixed-methods systematic review of pharmacist-administered injectable contraception: Insights from patients, pharmacists, and other health care professionals. J Am Pharm Assoc (2003). 2025 Feb 15:102360. doi: 10.1016/j.japh.2025.102360. Epub ahead of print. PMID: 39956291.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.